Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $180

Benzinga · 2d ago
Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:RGEN) with a Hold and raises the price target from $145 to $180.